GLP-1 outcomes: What weve learned and where payers need to focus next GLP-1s continue to be a focus in the healthcare industry
One more thing worth stating directly: women are not undertreated in peptide research because researchers do not care
McElya at Neighborhood Medical Center uses a science-backed approach that empowers you to achieve sustainable results rather than mere quick fixes
The small sample size of the GLP-1RA, however, limits generalizability, and baseline BMI differences may have influenced the observed outcomes
Fangming Chen, [email protected] These authors have contributed equally to this work and share first authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Yes, the weight came off quick, but I think there is just so much more to it that I didn't even expect. Roman P